Document Type
Article
Publication Date
3-28-2013
Publication Source
U.S. Patent and Trademark Office
Abstract
The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21 associated disorders, including metabolic conditions.
Document Version
Published Version
eCommons Citation
Boettcher, Brian R.; Caplan, Shari L.; Daniels, Douglas S.; Hamamatsu, Norio; Licht, Stuart; and Weldon, Stephen Craig, "Patent: Fusion Proteins for Treating Metabolic Disorders" (2013). Chemistry Faculty Publications. 102.
https://ecommons.udayton.edu/chm_fac_pub/102
Comments
Pub. No.: US 2013/007.9500 A1